Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: Bill Harmond who wrote (93653)	2/16/2000 10:49:00 AM
From: Glenn D. Rudolph	Respond to of 164684

Bought TXN at 136 1/2

To: Bill Harmond who wrote (93653)	2/16/2000 11:20:00 AM
From: mike machi	Respond to of 164684

Bought SCON @23 1/2 MM

To: Bill Harmond who wrote (93653)	2/16/2000 11:36:00 AM
From: H James Morris	Read Replies (1) \| Respond to of 164684

William, a few weeks ago I bought into a private placement @ 3.375. The company is called La Jolla pharmaceuticals (Ljpc). It's a apart of my San Diego fail-safe strategy.:-) Paid 23 1/4 for Scon. Bought Snra because it's Finnish. Sold some Voice Stream @ 155 even though it's Seattle based. Does this all make sense? Ps I think I'm close to being out of the IPO market.But will play out Inft.

To: Bill Harmond who wrote (93653)	2/16/2000 12:58:00 PM
From: Mark Fowler	Read Replies (2) \| Respond to of 164684

Scon looks very interesting its on my watch list ************************************************* HUMAN GENOME SCIENCES (185-1/32, up 30-9/32 @ 10:06 am ET) announced that it was issued a U.S. patent on a human gene that produces what is believed to be the critical entry point for the AIDS virus. The gene, known as the CCR5 receptor gene, gives rise in human cells to a protein that functions as a receptor or docking site for the human immunodeficiency virus. William remember Hysq? I think it's going to two hundred.